New protein-targeting drug shows promise in early trial for patients with high-risk CLL
A new oral targeted drug, idelalisib (GS-1101), has the potential to stave off the need for additional treatments for relapsed or treatment-resistant chronic lymphocytic leukemia (CLL), according to a study led in part by ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Australia: Stroke rates decline, but many still preventable
The rate of strokes suffered by Australians has dropped over the past 20 years, while strokes caused by an irregular heartbeat now account for one third of all strokes, according to new research led by the University of Adelaide.
Cardiology
May 16, 2013 |
not rated yet |
0
New class of potential drugs inhibits inflammation in brain
Scientists at Emory University School of Medicine have identified a new group of compounds that may protect brain cells from inflammation linked to seizures and neurodegenerative diseases.
Neuroscience
Feb 14, 2012 |
4.5 / 5 (4) |
0
|
Potential treatment prevents damage from prolonged seizures
A new type of prophylactic treatment for brain injury following prolonged epileptic seizures has been developed by Emory University School of Medicine investigators.
Neuroscience
Feb 11, 2013 |
not rated yet |
0
|
Can blood pressure drugs reduce the risk of dementia?
People taking the blood pressure drugs called beta blockers may be less likely to have changes in the brain that can be signs of Alzheimer's disease and other types of dementia, according to a study released today that will ...
Neuroscience
Jan 07, 2013 |
not rated yet |
0
|
Avastin disappoints against ovarian cancer
Avastin, the blockbuster drug that just lost approval for treating breast cancer, now looks disappointing against ovarian cancer, too. Two studies found it did not improve survival for most of these patients and kept their ...
Cancer
Dec 28, 2011 |
4.3 / 5 (4) |
1
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
Other
May 02, 2013 |
not rated yet |
0
FDA warns consumers of dangers of the stimulant DMAA
(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...
Health
Apr 15, 2013 |
5 / 5 (2) |
0
FDA approves 3 new drugs for type 2 diabetes
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Medications
Jan 26, 2013 |
5 / 5 (2) |
1
Heart hormone helps shape fat metabolism
It's well known that exercising reduces body weight because it draws on fat stores that muscle can burn as fuel. But a new study at Sanford-Burnham Medical Research Institute (Sanford-Burnham) suggests that ...
Medical research
Feb 06, 2012 |
5 / 5 (3) |
0
|
Everyday drugs could combat dementia, according to major study
(Medical Xpress)—Medications used to treat hypertension, diabetes and skin conditions could be doubling as treatments for Alzheimer's within 10 years according to researchers. A groundbreaking new study ...
Alzheimer's disease & dementia
Nov 01, 2012 |
not rated yet |
0
|
No proof drugs ease kids' migraines, study says
(HealthDay)—Children and teens who get migraine headaches suffer in multiple ways, missing school and fun time with friends while waiting for the debilitating pain to subside.
Pediatrics
Jan 28, 2013 |
5 / 5 (1) |
0
|
More pregnant women taking high blood pressure drugs, yet safety unclear
Nearly 5 percent of pregnant women are prescribed drugs to treat high blood pressure, including some drugs that aren't considered safe for mothers or their babies, according to new research in the American Heart Association's ...
Cardiology
Sep 10, 2012 |
not rated yet |
0
Common treatment for mild hypertension challenged
Doctors often prescribe drugs for people with mild high blood pressure with the hope of preventing cardiovascular disease (CVD). However, a new review from The Cochrane Library has found that this treatm ...
Diseases, Conditions, Syndromes
Aug 15, 2012 |
not rated yet |
0
|
FDA advisers recommend approving weight loss drug
(AP) -- Advisers to government health regulators on Thursday recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over ...
Medications
May 10, 2012 |
1 / 5 (1) |
0
